Skip to main content
. Author manuscript; available in PMC: 2017 Aug 11.
Published in final edited form as: J Low Genit Tract Dis. 2012 Oct;16(4):471–479. doi: 10.1097/LGT.0b013e3182472947

Table 2.

HPV status and genotype distribution in invasive vulvar cancer and in situ vulvar cancer (VIN3) cases, based on registry classification

Invasive (n=176) In Situ (VIN3) (n=68) P-value
N % N %


HPV positive 121 68.8 66 97.1 <.0001
HR-HPV* positive 119 67.6 64 94.1 <.0001
Individual HPV genotypes
 16 85 48.3 55 80.9
 18 3 1.7 1 1.5
 33 18 10.2 6 8.8
 52 5 2.8 0 0.0
 59 0 0.0 2 2.9
Multiple genotype, among all cases 11 6.3 4 5.9 1.00
Multiple genotypes, among HPV-positive samples 11 9.1 4 6.1 0.58
*

HR-HPV defined as types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68.

The following additional genotypes were tested and identified in <2% of all cases: 6, 11, 26, 31, 35, 39, 40, 42, 43, 44, 45, 51, 53, 54, 55, 56, 58, 61, 62, 64, 66, 67, 68, 69, 70, 71, 72, 73, 74, 81, 82, 83, 84, IS39 and X.